Evidence map›Paper›PMID 41305568›Full record

ArticleNutrients2025

Chen Liu, Yuqi Zhao, Jia Li, Shiqi Gao, Jin Cao, Na Jing, Xuemei Han, Hongpeng He, Wu Liang, Nan Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chen LiuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.ORCID 0000-0003-4905-6729
Yuqi ZhaoCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Jia LiCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Shiqi GaoCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Jin CaoCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Na JingCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Xuemei HanTianjin Key Laboratory of Edible Probiotics, Tianjin 300301, China.
Hongpeng HeCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Wu LiangTianjin Key Laboratory of Edible Probiotics, Tianjin 300301, China.
Nan WangCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.

Funding

Jinan Innovation Team Project No. 202228040Tianjin Science and Technology Achievement Transfer and Transformation Project No.24ZYCGSY00390
6 · The paper itself

Abstract

backgroundBlue light-induced retinal photodamage represents a growing public health concern globally. Lactic acid bacteria and their bioactive metabolites represent a promising therapeutic strategy for mitigating such damage.

methodsThis study evaluated the protective efficacy of

resultsIn ARPE-19 cells exposed to blue light, treatment with postbiotics from IOB802 and IOB602 significantly restored cell viability (

conclusionsIn summary, IOB802 and its postbiotics alleviate blue light-induced retinopathy through antioxidative, anti-inflammatory, and microbiota-modulating mechanisms, offering novel insights into microbiome-based interventions for retinal diseases.

Indexed as

Gastrointestinal MicrobiomeLightLimosilactobacillus fermentumProbioticsRetinal DiseasesAnimalsAntioxidantsBlue LightCell LineCytokinesDisease Models, AnimalHumansLactiplantibacillus plantarumMaleMiceMice, Inbred C57BLAntioxidantsCytokinesantioxidantblue lightgut microbiotaretina

Identifiers

PMID41305568
PMCPMC12655542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.